Natixis’s Aurora Cannabis ACB Stock Holding History

Natixis’s Portfolio ACB Stock Details ACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-380	Closed	-$2.64K	–	1009
2023 Q1	$2.64K	Hold	380	–	–	﹤0.01%	932
2022 Q4	$3.51K	Buy	+380	New	+$4.53K	﹤0.01%	1026

Other funds holding ACB

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Natixis's ACB Position: Q2 2023 in Review

Natixis sold out of Aurora Cannabis (ACB) in Q2 2023, closing a stake of 380 shares — an estimated $2.64K sold.

Natixis first reported a position in ACB in Q4 2022 and held it in 2 quarters. The position peaked at $3.51K in Q4 2022. 195 funds tracked by Wall St. Rank hold ACB as of Q2 2023.

Natixis reported no remaining Aurora Cannabis position as of Q2 2023 after selling out during the quarter.
Natixis sold 380 Aurora Cannabis shares in Q2 2023, an estimated $2.64K.
Natixis first reported a position in Aurora Cannabis in Q4 2022 and held it in 2 quarters.
Natixis's Aurora Cannabis position peaked at $3.51K in Q4 2022.
195 funds tracked by Wall St. Rank held Aurora Cannabis as of Q2 2023.

Based on Natixis's 13F filing for Q2 2023, filed 11 Aug 2023.